An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …

Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large
Inequalities | PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse …

Background The cost-effectiveness of prophylactic vaccination against human
papillomavirus types 16 (HPV-16) and 18 (HPV-18) is an important consideration for …

Background Coverage levels for many recommended adult vaccinations are low. The cost-
effectiveness research literature on adult vaccinations has not been synthesized in recent …

Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …

Objective To assess the cost effectiveness of including preadolescent boys in a routine
human papillomavirus (HPV) vaccination programme for preadolescent girls. Design Cost …

Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …

Background The availability of human papillomavirus (HPV) DNA testing and vaccination
against HPV types 16 and 18 (HPV-16, 18) motivates questions about the cost-effectiveness …

Objectives: One of the two new human papillomavirus (HPV) vaccines protects against HPV
types 6 and 11, which cause over 95% of genital warts, in addition to protecting against HPV …